CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 58  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0773
LYS 10.0453
GLU 20.0619
LEU 30.0550
ARG 40.0150
CYS 50.0235
GLN 60.0209
CYS 70.0282
ILE 80.0437
LYS 90.0377
THR 100.0207
TYR 110.0192
SER 120.0240
LYS 130.0249
PRO 140.0106
PHE 150.0014
HIS 160.0136
PRO 170.0081
LYS 180.0137
PHE 190.0139
ILE 200.0129
LYS 210.0237
GLU 220.0180
LEU 230.0088
ARG 240.0100
VAL 250.0118
ILE 260.0167
GLU 270.0333
SER 280.0337
GLY 290.0773
PRO 300.0441
HIS 310.0136
CYS 320.0171
ALA 330.0454
ASN 340.0241
THR 350.0208
GLU 360.0139
ILE 370.0148
ILE 380.0105
VAL 390.0086
LYS 400.0112
LEU 410.0108
SER 420.0154
ASP 430.0123
GLY 440.0128
ARG 450.0163
GLU 460.0031
LEU 470.0085
CYS 480.0024
LEU 490.0083
ASP 500.0104
PRO 510.0165
LYS 520.0395
GLU 530.0213
ASN 540.0165
TRP 550.0252
VAL 560.0204
GLN 570.0189
ARG 580.0158
VAL 590.0135
VAL 600.0129
GLU 610.0096
LYS 620.0102
PHE 630.0039
LEU 640.0030
LYS 650.0066
ARG 660.0053
ALA 670.0051
GLU 680.0203
ASN 690.0125

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.